Read the full stored bill text
Req. No. 3520 Page 1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
STATE OF OKLAHOMA
2nd Session of the 60th Legislature (2026)
SENATE BILL 1822 By: Jett
AS INTRODUCED
An Act relating to medical marijuana licenses;
authorizing certain research license; establishing
certain license purpose; providing certain
eligibility; requiring promulgation of certain rules;
establishing certain fees; providing for
codification; and providing an effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. NEW LAW A new section of law to be codified
in the Oklahoma Statutes as Section 427.19a of Title 63, unless
there is created a duplication in numbering, reads as follows:
A. The Oklahoma Medical Marijuana Authority shall be authorized
to create a research license to facilitate the collection, analysis,
and monitoring of patient-reported outcomes related to the use of
medical marijuana.
B. Research licensees may evaluate medical marijuana products
available in this state to analyze patient-reported outcomes.
Licensees may allow eligible entities to conduct studies including,
but not limited to, surveys and data collection to analyze the
impact of medical marijuana on medical conditions.
Req. No. 3520 Page 2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
C. Entities eligible for a license pursuant to this section
shall be:
1. Research institutions;
2. Health care organizations;
3. Licensed cannabis businesses; and
4. Private research companies.
D. The initial, nonrefundable fee for a patient-reported
outcome research license shall be Five Hundred Dollars ($500.00).
E. The Authority shall promulgate rules related to the issuance
of licenses, application approvals, compliance monitoring, and
reporting requirements.
SECTION 2. This act shall become effective November 1, 2026.
60-2-3520 BRC 1/14/2026 10:27:02 PM